7
Participants
Start Date
July 1, 2015
Primary Completion Date
March 9, 2023
Study Completion Date
March 9, 2023
OCA 0.1mg
Tablets administered orally once daily.
OCA 1.5mg
Tablets administered orally once daily.
OCA 5mg
Tablets administered orally once daily.
Clinques University Saint-Luc, Brussels
Regina Margherita Children's Hospital, Turin
Hopital de la Timone, Marseille
Centre for Paediatric Hepatology, Bergamo
Hannover Medical School, Children's Hospital, Paediatric Gastroenterology and Hepatology,, Hanover
CHU de Toulouse Purpan-Hopital des Enfants, Toulouse
CHU Lille, Lille
APHP- Hopital Necker Enfants Malades, Paris
Soroka University Medical Center, Beersheba
Hadassah Medical Center, Jerusalem
Schneider Children's Medical Center, Petah Tikva
Shaare-Zedek Medical Center, Jerusalem
University Medical Center Gröningen-Beatrix, children's Hospital, Groningen
Instytut Pomnik-Centrum Zdrowia Dziecka, Warsaw
Passeig Vall d'Hebron, Barcelona
Hospital Materno-Infantil de Malaga, Málaga
Birmingham Children's Hospital, Birmingham
Lead Sponsor
Intercept Pharmaceuticals
INDUSTRY